Relief over the Federal Reserve’s slow-and-steady rates plans fueled another day of gains. The Nasdaq clocked a record close for the second session in a row. Sarepta Therapeutics rose after announcing plans to offer $225
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source






















